10513-26-5

Basic information

• Product Name: 2-BroMo-5,5-diMethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one
• Synonyms: 2-BroMo-5,5-diMethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one;2-BroMo-5,5-diMethyl-5,6-dihydro-4H-benzothiazol-7-one
• CAS NO: 10513-26-5
• Molecular Formula: C₉H₁₀BrNOS
• Molecular Weight: 260.1508
• Mol File: 10513-26-5.mol
• Article Data: 4

Chemical Properties

• Melting Point: 74 °C
• Boiling Point: 330.3±11.0 °C(Predicted)
• Appearance: /
• Density: 1.529±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -0.60±0.40(Predicted)
• CAS DataBase Reference: 2-BroMo-5,5-diMethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BroMo-5,5-diMethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one(10513-26-5)
• EPA Substance Registry System: 2-BroMo-5,5-diMethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one(10513-26-5)

Safety Data

• Hazardous Substances Data: 10513-26-5(Hazardous Substances Data)

Usage

General Description

2-Bromo-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one is a chemical compound that belongs to the class of organic compounds known as dihydrobenzothiazoles. This chemical structure is made up of a benzothiazole core that has been reduced (hydrogenated) to make it less reactive, which is further modified with a bromine atom at the 2nd position and two methyl groups at the 5th position. The presence of an oxygen atom denotes its status as a ketone. In the field of organic chemistry, it is valuable for use in various chemical reactions due to its unique structural features. However, specific information regarding its use in practical applications such as in pharmaceuticals or materials science is limited.

Upstream product

• 1629-95-4 2-amino-5,5-dimethyl-5,6-dihydro-4H-benzothiazol-7-one 

Downstream Products

• 123973-48-8 2-Amino-5,5-dimethyl-5,6,7,8-tetrahydro-4H-thiazolo<5.4-c>-azepin-8-one 
• 1052208-75-9 C₁₉H₂₂N₂O₂S 
• 1052208-78-2 C₁₉H₂₂N₂O₂S 
• 1052208-80-6 C₂₀H₂₄N₂O₂S 

Relevant articles and documents

FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS

A series of 5,5-dimethyl-5,6-dihydro-1,3-benzothiazol-7(4H)-one and 7,7-dimethyl-5,6,7,8-tetrahydro-4H-[1,3]thiazolo[5,4-c]azepin-4-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted benzofused mor

Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines

The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed.